Robert E. Haselow
Impact in
- Otorhinolaryngology top 1%
- Head and Neck Cancer Studies
- Dermatology top 5%
- Chemotherapy-related skin toxicity
Papers in
-
- Head and Neck Cancer Studies 11
-
- Chemotherapy-related skin toxicity 2
- Co-authors
- Charles Scott (4 shared papers)Muhyi Al‐Sarraf (4 shared papers)Thomas J. Ervin (4 shared papers)James G. Schwade (5 shared papers)George E. Laramore (4 shared papers)R. Gahbauer (3 shared papers)Bruce H. Campbell (3 shared papers)Seymour H. Levitt (3 shared papers)
- Journals
- International Journal of Radiation Oncology*Biology*Physics (9 papers)Cancer (3 papers)Supportive Care in Cancer (1 paper)Journal of Clinical Oncology (1 paper)Radiology (1 paper)
- Partner nations
- United States
In The Last Decade
Robert E. Haselow
20 papers receiving 880 citations
Robert E. Haselow's Hit Papers
Peers
Comparison fields: 5 of 43
- Otorhinolaryngology 519
- Dermatology 110
- Genetics 60
- Endocrinology, Diabetes and Metabolism 40
- Epidemiology 71
Countries citing papers authored by Robert E. Haselow
This map shows the geographic impact of Robert E. Haselow's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Robert E. Haselow with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Robert E. Haselow more than expected).
Fields of papers citing papers by Robert E. Haselow
This network shows the impact of papers produced by Robert E. Haselow. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Robert E. Haselow. The network helps show where Robert E. Haselow may publish in the future.
Co-authors
The 25 scholars most cited alongside Robert E. Haselow, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Adjuvant chemotherapy for resectable squamous cell carcinomas of the head and neck: Report of intergroup study 0034 Hit paper breakdown → | 1992 | 338 |
| 2 | 2010 | 123 | |
| 3 | 1978 | 72 | |
| 4 | 1981 | 67 | |
| 5 | 1993 | 64 | |
| 6 | 1985 | 52 | |
| 7 | 2010 | 48 | |
| 8 | 1992 | 31 | |
| 9 | 1993 | 27 | |
| 10 | 1996 | 27 | |
| 11 | 1994 | 20 | |
| 12 | 1981 | 17 | |
| 13 | 1998 | 17 | |
| 14 | 2000 | 14 | |
| 15 | 1991 | 10 | |
| 16 | 2016 | 8 | |
| 17 | 1980 | 4 | |
| 18 | 1992 | 4 | |
| 19 | 1982 | 1 | |
| 20 | 1999 | 1 |
About Robert E. Haselow
Robert E. Haselow is a scholar working on Otorhinolaryngology, Dermatology, Radiation, Endocrinology, Diabetes and Metabolism and Epidemiology, having authored 20 papers that have together received 945 indexed citations. Recurring topics across this work include Head and Neck Cancer Studies (11 papers), Chemotherapy-related skin toxicity (2 papers), Multiple and Secondary Primary Cancers (2 papers), Advanced Radiotherapy Techniques (2 papers), Intramuscular injections and effects (1 paper), Meningioma and schwannoma management (1 paper), Glioma Diagnosis and Treatment (1 paper) and Thyroid Cancer Diagnosis and Treatment (1 paper). The work is most often cited by research in Otorhinolaryngology (519 citations), Dermatology (110 citations), Genetics (60 citations), Endocrinology, Diabetes and Metabolism (40 citations) and Epidemiology (71 citations). Robert E. Haselow has collaborated with scholars based in United States. Frequent co-authors include Charles Scott, Muhyi Al‐Sarraf, Thomas J. Ervin, James G. Schwade, George E. Laramore, R. Gahbauer, Bruce H. Campbell, Seymour H. Levitt, John Robert Jacobs and Richard H. Wheeler. Their work appears in journals such as International Journal of Radiation Oncology*Biology*Physics, Cancer, Supportive Care in Cancer, Journal of Clinical Oncology and Radiology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.